Patterns of recurrence in early-stage oesophageal cancer after chemoradiotherapy and surgery compared with surgery alone

被引:50
作者
Robb, W. B. [1 ,2 ,3 ,4 ]
Messager, M. [1 ,2 ,3 ,4 ]
Dahan, L. [5 ]
Mornex, F. [7 ]
Maillard, E. [8 ]
D'Journo, X. B. [6 ]
Triboulet, J. -P. [1 ,3 ,4 ]
Bedenne, L. [9 ]
Seitz, J. -F. [5 ]
Mariette, C. [1 ,2 ,3 ,4 ]
机构
[1] Lille Univ Hosp, Dept Digest & Oncol Surg, Lille, France
[2] INSERM, Jean Pierre Aubert Res Ctr, UMR S 1172, F-59045 Lille, France
[3] ONCOLille, SIRIC, Lille, France
[4] Univ Lille Nord France, Lille, France
[5] Univ Aix Marseille, La Timone Hosp, Dept Digest Oncol, Marseille, France
[6] Hop Nord Marseille, Dept Thorac Surg, Marseille, France
[7] Pierre Benite Hosp, Dept Radiotherapy, Lyon, France
[8] Federat Francophone Cancerol Digest, Dept Biostat, Dijon, France
[9] Univ Hosp Dijon, Dept Gastroenterol, Dijon, France
关键词
RANDOMIZED-CONTROLLED-TRIAL; PHASE-III TRIAL; PREOPERATIVE CHEMORADIOTHERAPY; NEOADJUVANT CHEMORADIOTHERAPY; JUNCTIONAL CANCER; COMPLETE RESPONSE; CARCINOMA; CHEMORADIATION; CHEMOTHERAPY; SURVIVAL;
D O I
10.1002/bjs.9959
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Patterns of disease recurrence in patients with oesophageal cancer following treatment with neoadjuvant chemoradiotherapy and surgery (nCRTS) or surgery alone are poorly reported. An understanding of patterns of disease recurrence is important for subsequent treatment planning. Methods: An analysis was undertaken of patterns of disease recurrence from a phase III multicentre randomized trial (FFCD9901) comparing nCRTS with surgery alone in patients with stage I and II oesophageal cancer. Results: Some 170 patients undergoing surgical resection were included in the study. R0 resection rates were similar in the two groups: 94 per cent following nCRTS versus 92 per cent after surgery alone (P = 0.749). After a median follow-up of 94.2 months, recurrent disease was found in 39.4 per cent of the overall cohort (31 per cent after nCRTS versus 47 per cent following surgery alone; P = 0.030). Locoregional recurrence was diagnosed in 41 patients (17 versus 30 per cent respectively; P = 0.047) and distant metastatic recurrence in 47 (23 versus 31 per cent respectively; P = 0.244). Metastatic recurrence was more frequent in patients with adenocarcinoma than in those with squamous cell cancer ( 40 versus 23.1 per cent respectively; P = 0.032). ypT0N0 category was associated with prolonged time to mixed locoregional and metastatic recurrence (P = 0.009), and time to locoregional (P = 0.044) and metastatic (P = 0.055) recurrence. In multivariable analysis, node-positive disease predicted both locoregional (P = 0.001) and metastatic (P < 0.001) recurrence. Conclusion: Locoregional disease control following nCRTS indicated a local field effect not related solely to completeness of resection. pN+ disease was strongly predictive of time to locoregional and metastatic disease recurrence.
引用
收藏
页码:117 / 125
页数:9
相关论文
共 21 条
  • [1] Long-Term Results of a Randomized Trial of Surgery With or Without Preoperative Chemotherapy in Esophageal Cancer
    Allum, William H.
    Stenning, Sally P.
    Bancewicz, John
    Clark, Peter I.
    Langley, Ruth E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (30) : 5062 - 5067
  • [2] Ancona E, 2001, CANCER, V91, P2165, DOI 10.1002/1097-0142(20010601)91:11<2165::AID-CNCR1245>3.3.CO
  • [3] 2-8
  • [4] Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial
    Burmeister, BH
    Smithers, BM
    Gebski, V
    Fitzgerald, L
    Simes, RJ
    Devitt, P
    Ackland, S
    Gotley, DC
    Joseph, D
    Millar, J
    North, J
    Walpole, ET
    Denham, JW
    [J]. LANCET ONCOLOGY, 2005, 6 (09) : 659 - 668
  • [5] MANDARD AM, 1994, CANCER, V73, P2680, DOI 10.1002/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO
  • [6] 2-C
  • [7] Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease
    Mariette, C
    Balon, JM
    Piessen, G
    Fabre, S
    Van Seuningen, I
    Triboulet, JP
    [J]. CANCER, 2003, 97 (07) : 1616 - 1623
  • [8] Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities
    Mariette, Christophe
    Piessen, Guillaume
    Triboulet, Jean-Pierre
    [J]. LANCET ONCOLOGY, 2007, 8 (06) : 545 - 553
  • [9] Neoadjuvant chemoradiation in oesophageal cancer
    Mariette, Christophe
    Robb, William B.
    Piessen, Guillaume
    Adenis, Antoine
    [J]. LANCET ONCOLOGY, 2015, 16 (09) : 1008 - 1009
  • [10] Surgery Alone Versus Chemoradiotherapy Followed by Surgery for Stage I and II Esophageal Cancer: Final Analysis of Randomized Controlled Phase III Trial FFCD 9901
    Mariette, Christophe
    Dahan, Laetitia
    Mornex, Francoise
    Maillard, Emilie
    Thomas, Pascal-Alexandre
    Meunier, Bernard
    Boige, Valerie
    Pezet, Denis
    Robb, William B.
    Le Brun-Ly, Valerie
    Bosset, Jean-Francois
    Mabrut, Jean-Yves
    Triboulet, Jean-Pierre
    Bedenne, Laurent
    Seitz, Jean-Francois
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (23) : 2416 - U201